Still no green light for Phath­om's gas­troin­testi­nal drugs af­ter im­pu­ri­ties found in batch­es

Phath­om Phar­ma­ceu­ti­cals is still work­ing out the kinks of launch­ing two al­ready-ap­proved drugs for a bac­te­r­i­al in­fec­tion and snag­ging an NDA ap­proval for an­oth­er gas­troin­testi­nal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER